Wikidata

(Q63812090)

English

A Study of Atezolizumab Compared With Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Containing Therapy

clinical trial

In more languages

Statements

short name
IPSOS (English)
0 references
title
A Phase III, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Atezolizumab Compared With Chemotherapy in Patients With Treatment Naïve Advanced or Recurrent (Stage IIIb Not Amenable for Multimodality Treatment) or Metastatic (Stage IV) Non-Small Cell Lung Cancer Who Are Deemed Unsuitable for Platinum-Containing Therapy (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Argentina
0 references
Belgium
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Colombia
0 references
Denmark
0 references
Germany
0 references
India
0 references
Republic of Ireland
0 references
Italy
0 references
Kazakhstan
0 references
Luxembourg
0 references
Mexico
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Slovakia
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
Vietnam
0 references
start time
11 September 2017
0 references
end time
20 January 2021
0 references
number of participants
441
0 references
research intervention
gemcitabine
0 references
atezolizumab
0 references
vinorelbine
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63812090&oldid=2136468487"